1Mor G, Straszewski S, Kamsteeg M, et al. Role of the Fas/Fas ligand system in female eproductive organs: survival and apoptosis[J]. Biochem Pharmacol,2002,64(9) : 1305-1315.
2Sabelko KA,Kelly KA, Nahm MH, et al. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system[ J]. J Immunol 1997,159(7) :3096-3099.
3Sablko-Downes KA, Russell JH, Cross AH. Role of Fas-Fasl interactions in the pathogenesis and regulation of autoimmune demyelinating disease [J] .J Neuroimmunol, 1999,100(1-2) :42-52.
4Wajant H, Haas E, Schwenzer R, et al. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD)[J] .J Biol Chem,2000,275(32) :24357-24366.
5Bonetti B, Pohl J, Gao YL, et al. Cell death during autoimmune demyelination:effector but not target cells are eliminated by apoptosis[ J]. J Immunol, 1997,159(11) :5733-5741.
6Ouallet J, Banmann N, Marie Y, et al. Fas system up-regulation in experimental autoimmune encephalomyelitis[ J]. J Neurol Sci, 1999, 170(2) :96-106.
7Zang YC, Kozovska MM, Hong J, et al. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis[J] .Eur J Immunol, 1999,29(5) : 1692-1700.
8Comi C, Leone M, Bonissoni S, et al. Defective T cell fas function in patients with multiple sclerosis[J]. Neurology,2000,55(7):921-927.
9Huang WX, Huang MP, Comes MA, et al. Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS[ J ]. Nurology, 2000,55 ( 7 ) : 928-934.
10Bonnetti B, Raine CS. Multiple Scllerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis[ J]. Ann Neurol, 1997,42 ( 1 ) : 74-84.
